Friday, Apr 19, 2024 | Last Update : 10:11 PM IST

biopharmaceutical

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

ADVERTISEMENT
ADVERTISEMENT